Qube Research & Technologies (QRT)
BOLD icon

Qube Research & Technologies (QRT)’s Boundless Bio BOLD Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio BOLD Stock Details BOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$50.5K Buy
20,207
+2,715
+16% +$4.18K ﹤0.01% 3124
2026
Q1 		$19.2K Sell
17,492
-1,215
-6% -$1.42K ﹤0.01% 3271
2025
Q4 		$22.4K Buy
18,707
+660
+4% +$822 ﹤0.01% 3373
2025
Q3 		$22.2K Sell
18,047
-3,495
-16% -$4.03K ﹤0.01% 3283
2025
Q2 		$21.8K Buy
+21,542
New +$28.6K ﹤0.01% 3250

Other funds holding BOLD

Arch Venture Management
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
ADAR1 Capital Management
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Cormorant Asset Management
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Qube Research & Technologies (QRT)'s BOLD Position: Q2 2026 in Review

Qube Research & Technologies (QRT) increased its Boundless Bio (BOLD) stake by 16% in Q2 2026, buying an estimated $4.18K and bringing the position to 20,207 shares worth $50.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3124.

Qube Research & Technologies (QRT) first reported a position in BOLD in Q2 2025 and has held it in 5 quarters since. 40 funds tracked by Wall St. Rank hold BOLD as of Q2 2026.

  • Qube Research & Technologies (QRT) held 20,207 shares of Boundless Bio worth $50.5K as of Q2 2026.
  • Qube Research & Technologies (QRT) bought 2,715 Boundless Bio shares in Q2 2026, an estimated $4.18K.
  • Boundless Bio made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #3124 holding.
  • Qube Research & Technologies (QRT) first reported a position in Boundless Bio in Q2 2025 and has held it in 5 quarters since.
  • 40 funds tracked by Wall St. Rank held Boundless Bio as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.